Recent Updates
Recently added Catalysts
COLL Positive Sentiment Score: 65/100

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Thursday, February 8, 2024 1 min read
Key Takeaway: Collegium Pharmaceutical, Inc. announced that it will report its fourth quarter and full-year 2023 financial results on February 22, 2024. Following the release, the company will hold a live conference call and webcast to discuss the details. This event illustrates Collegium's commitment to communication with stakeholders and provides an opportunity for investors to gain insights into the company's performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Collegium Pharmaceutical is committed to improving lives with serious medical conditions.
  • The company continues to engage with investors through conference calls.
  • An upcoming financial results announcement indicates transparency and accountability.

Full Press Release Details

STOUGHTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report fourth quarter and full-year 2023 financial results after the market closes on Thursday, February 22, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q4 2023 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Christopher James, M.D.
Vice President, Investor Relations
ir@collegiumpharma.com
Vice President, Corporate Communications
communications@collegiumpharma.com

Frequently Asked Questions

When will Collegium report its Q4 2023 financial results?

Collegium will report its Q4 2023 financial results on February 22, 2024.

What time is the Collegium earnings call scheduled?

The earnings call is scheduled for 4:30 p.m. ET on February 22, 2024.

How can I access the Collegium earnings call?

You can access the call by dialing (877) 407-8037 for the U.S. and (201) 689-8037 for international callers.

Where can I find the webcast for the earnings call?

The audio webcast will be available in the Investors section of Collegium’s website.

What is Collegium Pharmaceutical's main focus?

Collegium is focused on improving the lives of those with serious medical conditions.

Tags: COLL Viatris Investor Conferences Healthcare Collegium Pharmaceutical financial results Earnings Call Stoughton Q4 2023
Last updated: Feb 8, 2024